The headline answer: testosterone cypionate has an effective half-life of ~8 days, so it reaches steady state in roughly 4 to 5 weeks (five half-lives) of consistent dosing. Enanthate stabilizes slightly faster (T½ ~6 d, ~30 days), propionate within ~10 days, and topical gel within ~2 days. If you draw labs before that window closes, you are not seeing the true level your protocol will hold — you are sampling a still-accumulating curve.
Steady state is the point at which the rate of drug entering your bloodstream equals the rate at which your body clears it. After repeated dosing, the peak-to-trough cycle becomes identical from one dose to the next, oscillating around a constant average instead of climbing each week.
For TRT this matters practically: every clinical decision should be based on a steady-state draw. Anything earlier is a transient. A 100 mg weekly cypionate protocol might produce ~450 ng/dL after one shot but ~700 ng/dL once accumulated. The FDA Depo-Testosterone label reports peak plasma at 24-48 h with a multi-day terminal phase, which is why weekly dosing produces peaks and troughs rather than a flat line.
Testosterone cypionate reaches steady state in approximately 4-5 weeks of stable dosing. The effective half-life is ~8 days (192 hours), driven by slow release from the intramuscular oil depot. Five half-lives lands at ~40 days, by which point further accumulation contributes less than ~3% — the conventional definition of "steady state."
This holds whether you dose weekly, twice-weekly, or every-other-day — frequency changes the smoothness, not the time to stabilize. Skipping a shot or rotating esters resets the clock partially. The Endocrine Society 2018 Guideline (Bhasin et al.) recommends rechecking testosterone 6-12 weeks after starting or adjusting therapy — past the 5-half-life window for cypionate and enanthate.
The 5-half-life rule comes directly from exponential decay. After each half-life, you reach the next halfway point between your current level and the asymptotic steady-state ceiling. The percentages compound: 50%, then 75%, then 87.5%, then 93.75%, then ~96.9%. By the fifth half-life, you are within ~3% of the final value and the rest of the curve is asymptotically flat.
| Half-lives elapsed | % of steady state reached | Cypionate (T½ ≈ 8 d) |
|---|---|---|
| 1 | 50.0% | ~8 days |
| 2 | 75.0% | ~16 days |
| 3 | 87.5% | ~24 days |
| 4 | 93.75% | ~32 days |
| 5 | ~96.9% | ~40 days |
| 7 | ~99.2% | ~56 days |
These percentages are derived from the standard accumulation equation, where the fraction of steady state at time t is 1 − (1/2)t/T½. Most clinical pharmacology texts adopt 5 half-lives as the practical threshold; for TRT, where lab assay variability already exceeds 5%, the difference between 4 and 5 half-lives is clinically irrelevant.
After a single cypionate or enanthate injection, plasma testosterone climbs from baseline to a peak (Tmax) at roughly 24-48 hours, then decays toward baseline over 1-2 weeks. That single arc is not the saw-tooth your weekly schedule will eventually produce.
At steady state, the arc has stacked four or five times. The trough is elevated above your natural baseline because residual drug from prior doses is still being released. Concretely: a 150 mg weekly cypionate protocol might produce a single-injection peak of ~800 ng/dL and a 7-day return to baseline. At steady state, the same protocol holds a trough around 500-650 ng/dL and a peak of 1000-1200 ng/dL, repeating identically every 7 days.
This is why the most common TRT pitfall is judging a protocol from a 2- or 3-week lab. A 600 ng/dL trough at week 2 looks "perfect" — but the curve is still climbing. The week-6 trough on the same protocol may land at 750 ng/dL with peaks above the upper reference range.
For weekly or twice-weekly cypionate or enanthate, draw labs at the trough — the morning of your next scheduled injection, before injecting. This captures the lowest plasma concentration in your cycle. The Endocrine Society 2018 guideline recommends rechecking testosterone roughly 6-12 weeks after initiating or adjusting therapy — past the 5-half-life threshold for both esters.
Trough draws are standard because they answer the most clinically meaningful question: does my protocol keep me in range at the worst point of the cycle? If the trough is in range, the peak is by definition covered. Peak draws (24-48 h post-injection) tell you whether you are over-shooting.
For shorter esters, the calculus shifts. Propionate users draw mid-cycle (~24 h post-injection) since the cycle is too brief for a meaningful trough. Daily gel users draw 2-8 hours after application per the StatPearls testosterone monograph. Always confirm timing with your lab and prescriber.
Effective half-life is the variable that matters. Cypionate, enanthate, and propionate all release the same molecule (free testosterone) with the same true ~10-hour elimination half-life. What differs is the depot release rate, which dictates the apparent half-life and time to steady state.
| Formulation | Effective T½ | Time to steady state (5 × T½) | Bloodwork timing | Source |
|---|---|---|---|---|
| Cypionate (Depo-Testosterone) | ~8 days | ~40 days | Trough (just before next injection) | FDA label |
| Enanthate (Delatestryl, Xyosted) | ~6 days (4.5-7) | ~30 days | Trough | Nieschlag 1992 |
| Propionate | ~2 days | ~10 days | Mid-cycle (24h post-injection) | StatPearls |
| Topical gel (AndroGel, Testim) | ~10 hours | ~2 days | 2-8h post-application | StatPearls |
Practical implications: switching from cypionate to gel takes weeks to wash out, even though gel itself stabilizes in days — the residual depot still needs ~5 half-lives to clear. And propionate's faster turnover makes it useful for fine-tuning: a dose change yields a steady-state result in 10 days rather than 5 weeks.
Flip-flop kinetics describe a situation where absorption is slower than elimination, so the absorption rate constant (kₐ) — not the elimination rate constant (kₑ) — controls the apparent half-life. For testosterone esters, free testosterone clears from the bloodstream in about 10 hours once liberated from the ester, but the ester's release from the IM oil depot takes days. The slower step wins.
This explains why "testosterone half-life" is sometimes quoted as 10 hours and sometimes as 8 days. The 10-hour figure is true elimination of free testosterone. The 8-day figure is the apparent half-life of cypionate, dominated by depot release. Steady-state calculations always use the apparent half-life.
Topical gel breaks the flip-flop pattern. Transdermal absorption is fast (kₐ ≈ 0.3 h⁻¹), so true elimination becomes rate-limiting and the 10-hour half-life governs. Daily gel users see large day-to-day swings because there is no depot to buffer the dose.
Dose Track's Dial-In simulator shows your full steady-state trajectory before you commit. Pick an ester, dose, and frequency; the chart projects 8 weeks ahead so you can see where your trough, peak, and average will land — and whether your bloodwork date sits inside or outside the 5-half-life window. Compare cypionate weekly vs twice-weekly, swap in enanthate or gel, or model dose changes mid-cycle. See TRT tracking features, browse the medications library, or download free on the App Store.